SSRIs vs. Ketamine: When Antidepressants Aren't Enough

Nobody starts depression treatment with ketamine, and nobody should. SSRIs and their cousins are first-line for good reasons: decades of safety data, insurance coverage, a daily pill's convenience, and solid effectiveness for many people. This comparison is really about the moment that matters: what to do when the second or third medication hasn't worked.

Fundamentally different tools

• SSRIs/SNRIs (sertraline, escitalopram, venlafaxine, and the rest) raise serotonin or norepinephrine signaling, with therapeutic effects building over 4–8 weeks of daily dosing.
• Ketamine acts on the glutamate system (NMDA-receptor blockade), triggering a rapid burst of synaptic growth. Effects arrive in hours to days from intermittent sessions rather than daily pills.

That mechanistic difference is why ketamine can work for people multiple antidepressants have failed — it's not "a stronger SSRI," it's a different lever entirely.

The numbers worth knowing

The large STAR*D study mapped what happens with sequential medication trials: about a third of patients remit on their first antidepressant, and the odds drop with each subsequent switch — by the third and fourth medication, remission rates fall to roughly 10–15%. Meanwhile ketamine trials in exactly this treatment-resistant population show response rates commonly in the 50–70% range for the initial series.

That's the honest case for not grinding through a fifth medication trial by default. The honest counterpoints: ketamine's effects fade without maintenance, it's usually cash-pay, and daily SSRIs remain far cheaper and simpler when they work.

"Treatment-resistant" is a specific threshold

Clinically — and for Spravato insurance coverage — treatment-resistant depression usually means two or more adequate antidepressant trials (right dose, 6+ weeks each) without sufficient improvement. Two important honesty checks before you count yourself in:

1. Were the trials adequate? Many "failed" medications were actually stopped early or underdosed. A medication review with a psychiatrist sometimes rescues an option you thought was exhausted.
2. Was augmentation tried? Adding a second agent to a partial responder is a standard, insurance-covered step that sometimes works when switching doesn't.

If you're genuinely past that threshold, you're in the population where ketamine has its strongest evidence — and where our PHQ-9 screening can help you track whatever you try next.

Practical comparison

• Speed: SSRIs 4–8 weeks; ketamine hours to days. In severe episodes this difference is not cosmetic.
• Logistics: a daily pill vs. clinic sessions with monitoring and a ride home (or supervised at-home protocols).
• Cost: generic SSRIs cost a few dollars a month with insurance; ketamine runs $2,400–$4,800 for an initial series plus maintenance, with Spravato the covered exception.
• Side effects: SSRIs — sexual dysfunction, weight change, emotional blunting, discontinuation symptoms; ketamine — dissociation during sessions, blood-pressure elevation, misuse potential, and bladder risk with heavy frequent use.
• Stopping: SSRIs need tapering; ketamine simply wears off (which is also its durability problem).

They're not rivals in practice

Most ketamine patients stay on their antidepressants — the treatments combine safely and many clinicians believe a stable medication foundation helps maintain ketamine's gains. Ketamine is also not a reason to abandon psychotherapy; if anything, the post-session neuroplasticity window makes therapy more valuable.

One interaction worth knowing: benzodiazepines (and possibly lamotrigine) can blunt ketamine's effects — disclose everything you take during clinic screening.

Bottom line

Use the cheap, covered, well-understood tools first, and use them properly. But if two or more real medication trials haven't worked, the evidence doesn't say "keep switching forever" — it says your odds with another SSRI are low and your odds with ketamine-class treatment are meaningfully better. That's the point to talk to a psychiatrist about sequencing, check your Spravato eligibility, and see what's available near you.